Anna Raciborska
the Institue of Mother and Child · Mother and Child Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anna Raciborska as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:50 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05968768 · To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)Anna Raciborska · recruiting · Ewing Sarcoma · principal investigator
- Ph1/Ph2NCT05395741 · Regorafenib in Patients With Refractory Primary Bone TumorsInstitute of Mother and Child, Warsaw, Poland · completed · Osteosarcoma, Ewing Sarcoma of Bone · principal investigator
- Ph2NCT04943198 · Optimization of the Time and Dosage of Vemurafenib in BRAF Positive Juvenile Patients With Refractory HistiocytosisAnna Raciborska · active not recruiting · Histiocytosis · principal investigator
- Ph2NCT04943224 · Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile PatientsAnna Raciborska · active not recruiting · Histiocytosis · principal investigator
- Ph3NCT04943211 · Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT ImagingAnna Raciborska · active not recruiting · Histiocytosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:50 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma.Pediatr Blood Cancer · 201380 citationsRCR 2.6
- High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.J Clin Oncol · 202247 citationsRCR 3.9
- Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.Clin Cancer Res · 202310 citationsRCR 1.1
- Feasibility and Safety of Treosulfan, Melphalan, and Thiotepa-Based Megachemotherapy with Autologous or Allogeneic Stem Cell Transplantation in Heavily Pretreated Children with Relapsed or Refractory Neuroblastoma.Biol Blood Marrow Transplant · 20194 citationsRCR 0.2